Código QR

Current insights into monitoring of congenital adrenal hyperplasia

The management of 21-hydroxylase deficiency (21OHD), the most common form of congenital adrenal hyperplasia, remains challenging as both over- and undertreatment with hormone replacement therapy are associated with short and long-term complications. Monitoring of treatment efficacy typically combine...

ver descrição completa

Na minha lista:
Principais autores: Quinty M. Leusink, Elke E. W. Verploegen, Bas P. H. Adriaansen, Xinyi Chin, Nike M. M. L. Stikkelbroeck, Paul N. Span, Fred C. G. J. Sweep, Margo Dona, Antonius E. van Herwaarden, Hedi L. Claahsen-van der Grinten
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2026-02-01
Colecção:Frontiers in Endocrinology
Assuntos:
congenital adrenal hyperplasia (CAH)
21-hydroxylase deficiency (21OHD)
monitoring
biomarkers
reference intervals
Acesso em linha:https://www.frontiersin.org/articles/10.3389/fendo.2026.1774145/full
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados